Gad Thomas

Number of records: 50
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
07-Mar-24 5:01 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 05-Mar-24Private Sale 3,900$16.44$64,116.00(< 1%)
487.63K to 483.73K
22-Jan-24 5:52 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 18-Jan-24Grant 22,100----5%
465.53K to 487.63K
26-Dec-23 4:15 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 21-Dec-23Option Exercise 50,000$2.00$100,000.0012%
415.53K to 465.53K
15-Dec-23 7:40 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 15-Dec-23Sale 50,000$6.61$330,500.00(11%)
465.53K to 415.53K
15-Dec-23 7:40 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 14-Dec-23Sale 50,000$6.83$341,500.00(10%)
515.53K to 465.53K
15-Dec-23 7:40 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 13-Dec-23Sale 50,000$6.58$329,000.00(9%)
565.53K to 515.53K
22-Nov-23 5:00 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 21-Nov-23Sale 75,000$5.31$397,988.00(12%)
640.53K to 565.53K
22-Nov-23 5:00 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 20-Nov-23Sale 75,000$5.30$397,395.00(10%)
715.53K to 640.53K
19-Jan-23 4:42 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 17-Jan-23Grant 40,500----6%
675.03K to 715.53K
09-Feb-22 6:59 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 09-Feb-22Sale 64,276$6.96$447,117.00(9%)
739.31K to 675.03K
09-Feb-22 6:59 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 08-Feb-22Sale 125,863$7.01$882,891.00(15%)
865.17K to 739.31K
09-Feb-22 6:59 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 07-Feb-22Sale 91,031$7.59$691,180.00(10%)
956.2K to 865.17K
07-Feb-22 5:15 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 04-Feb-22Sale 101,104$7.70$778,531.00(10%)
1.06M to 956.2K
07-Feb-22 5:15 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 03-Feb-22Sale 35,060$7.90$277,027.00(3%)
1.09M to 1.06M
03-Feb-22 5:00 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 01-Feb-22Option Exercise 8,000$2.00$16,000.00< 1%
1.09M to 1.1M
03-Feb-22 5:00 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 01-Feb-22Option Sale 8,000$10.15$81,160.80(< 1%)
1.1M to 1.09M
26-Jan-22 5:09 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 24-Jan-22Sale 88,055$10.63$936,412.00(7%)
1.18M to 1.09M
24-Jan-22 5:39 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 21-Jan-22Sale 70,318$10.75$755,815.00(6%)
1.25M to 1.18M
24-Jan-22 5:39 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 20-Jan-22Sale 112,767$11.33$1,277,290.00(8%)
1.36M to 1.25M
20-Jan-22 5:13 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 19-Jan-22Sale 69,414$10.89$756,092.00(5%)
1.43M to 1.36M
20-Jan-22 5:13 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 18-Jan-22Option Exercise 8,000$2.00$16,000.00< 1%
1.43M to 1.44M
20-Jan-22 5:13 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 18-Jan-22Option Sale 8,000$11.54$92,314.40(< 1%)
1.44M to 1.43M
20-Jan-22 5:13 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 18-Jan-22Sale 400$11.46$4,584.00(< 1%)
1.43M to 1.43M
16-Dec-21 6:35 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 14-Dec-21Gift 60,000----2%
2.76M to 2.82M
16-Dec-21 6:35 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 14-Dec-21Gift 60,000----(2%)
2.82M to 2.76M
08-Dec-21 5:18 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 07-Dec-21Market Sale 10,000$17.58$175,832.00(< 1%)
1.44M to 1.43M
1%
08-Dec-21 5:18 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 06-Dec-21Market Sale 44,000$16.48$725,242.00(3%)
1.49M to 1.44M
(6%)
01-Dec-21 5:15 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 30-Nov-21Market Sale 21,170$17.08$361,545.00(1%)
1.51M to 1.49M
(< 1%)
01-Dec-21 5:15 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 30-Nov-21Market Sale (Planned) 4,000$16.98$67,912.40(< 1%)
1.49M to 1.49M
(< 1%)
01-Dec-21 5:15 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 29-Nov-21Market Sale 22,437$17.16$385,026.00(1%)
1.53M to 1.51M
< 1%
26-Nov-21 5:33 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 23-Nov-21Option Exercise 50,000$2.00$100,000.003%
1.53M to 1.58M
26-Nov-21 5:33 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 23-Nov-21Market Option Sale 50,000$17.06$852,850.00(3%)
1.58M to 1.53M
18-Nov-21 5:18 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 16-Nov-21Market Sale (Planned) 4,000$19.33$77,302.00(< 1%)
1.54M to 1.53M
2%
01-Nov-21 5:15 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 29-Oct-21Market Sale (Planned) 4,000$24.82$99,260.80(< 1%)
1.54M to 1.54M
1%
19-Oct-21 5:17 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 15-Oct-21Market Sale (Planned) 4,000$27.20$108,799.00(< 1%)
1.55M to 1.54M
2%
04-Oct-21 5:17 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 30-Sep-21Market Sale (Planned) 4,000$28.26$113,054.00(< 1%)
1.55M to 1.55M
(4%)
17-Aug-21 6:32 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 17-Aug-21Market Sale 1,779$28.96$51,527.00(< 1%)
1.56M to 1.55M
(< 1%)
17-Aug-21 6:32 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 16-Aug-21Market Sale 22,111$29.33$648,527.00(1%)
1.58M to 1.56M
1%
17-Aug-21 6:32 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 16-Aug-21Market Sale (Planned) 4,000$29.14$116,544.00(< 1%)
1.56M to 1.56M
< 1%
17-Aug-21 6:32 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 13-Aug-21Market Sale 1,110$31.01$34,425.60(< 1%)
1.58M to 1.58M
7%
05-Aug-21 10:00 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 03-Aug-21Market Sale (Planned) 4,000$33.73$134,927.00(< 1%)
1.59M to 1.58M
13%
21-Jul-21 6:56 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 20-Jul-21Market Sale (Planned) 4,000$32.47$129,875.00(< 1%)
1.59M to 1.59M
(< 1%)
08-Jul-21 5:16 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 07-Jul-21Market Sale (Planned) 4,000$31.87$127,465.00(< 1%)
1.6M to 1.59M
(< 1%)
02-Jul-21 4:31 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 30-Jun-21Market Sale (Planned) 4,000$33.86$135,446.00(< 1%)
1.6M to 1.6M
(4%)
15-Jun-21 5:06 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 14-Jun-21Market Sale (Planned) 4,000$35.80$143,217.00(< 1%)
1.6M to 1.6M
(2%)
01-Jun-21 4:32 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 28-May-21Market Sale (Planned) 4,000$36.95$147,813.00(< 1%)
1.61M to 1.6M
3%
20-May-21 4:32 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 18-May-21Market Sale (Planned) 4,000$34.07$136,290.00(< 1%)
1.61M to 1.61M
2%
28-Apr-21 4:16 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 26-Apr-21Option Exercise 7,000$2.00$14,000.00< 1%
1.61M to 1.62M
28-Apr-21 4:16 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 26-Apr-21Market Option Sale (Planned) 7,000$27.96$195,730.00(< 1%)
1.62M to 1.61M
14-Apr-21 5:00 PM
View: 
Y-Mabs Therapeutics, Inc. (YMAB) 12-Apr-21Option Exercise 7,000$2.00$14,000.00< 1%
1.62M to 1.62M